BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li MY, Deng H, Zhao JM, Dai D, Tan XY. PPARγ pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells. World J Gastroenterol 2003; 9(6): 1220-1226 [PMID: 12800228 DOI: 10.3748/wjg.v9.i6.1220]
URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1220.htm
Number Citing Articles
Belinda Knight, Bu B. Yeap, George C. Yeoh, John K. Olynyk. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member γ, but not α or δCarcinogenesis 2005; 26(10): 1782 doi: 10.1093/carcin/bgi138
Geneviève Drouin, Annie Douillette, Pierre Lacasse, Benoit Paquette. Effet radiosensibilisateur de l'acide linoléique conjugué chez les cellules cancéreuses du sein MCF-7 et MDA-MB-231Canadian Journal of Physiology and Pharmacology 2004; 82(2): 94 doi: 10.1139/y04-003
Cai-Yan Zhao, Ling-Ling Jiang, Li Li, Zhuo-Jun Deng, Bao-Li Liang, Jian-Mei Li. Peroxisome proliferator activated receptor-γ in pathogenesis of experimental fatty liver diseaseWorld Journal of Gastroenterology 2004; 10(9): 1329-1332 doi: 10.3748/wjg.v10.i9.1329
Kenichi Harada, Kumiko Isse, Takashi Kamihira, Shinji Shimoda, Yasuni Nakanuma. Th1 cytokine-induced downregulation of PPARγ in human biliary cells relates to cholangitis in primary biliary cirrhosisHepatology 2005; 41(6): 1329 doi: 10.1002/hep.20705
Hajime Nozawa, Wakako Nakao, Feng Zhao, Keiji Kondo. Dietary supplement of isohumulones inhibits the formation of aberrant crypt foci with a concomitant decrease in prostaglandin E2 level in rat colonMolecular Nutrition & Food Research 2005; 49(8): 772 doi: 10.1002/mnfr.200500027
Saswati Hazra, Katherine A. Peebles, Sherven Sharma, Jenny T. Mao, Steven M. Dubinett, Dipak Panigrahy. The Role of PPARγ in the Cyclooxygenase Pathway in Lung CancerPPAR Research 2008; 2008(1) doi: 10.1155/2008/790568
Suniket V. Fulzele, Abhijit Chatterjee, Madhu Sudhan Shaik, Tanise Jackson, Mandip Singh. Inhalation Delivery and Anti-tumor Activity of Celecoxib in Human Orthotopic Non-Small Cell Lung Cancer Xenograft ModelPharmaceutical Research 2006; 23(9): 2094 doi: 10.1007/s11095-006-9074-6
Takayuki Ohshima, Hiroshi Koga, Kunitada Shimotohno. Transcriptional Activity of Peroxisome Proliferator-activated Receptor γ Is Modulated by SUMO-1 ModificationJournal of Biological Chemistry 2004; 279(28): 29551 doi: 10.1074/jbc.M403866200
Yukiko K. Nakamura, Stanley T. Omaye. Vitamin E-modulated gene expression associated with ROS generationJournal of Functional Foods 2009; 1(3): 241 doi: 10.1016/j.jff.2009.02.002
ShouWei Han, Jesse Roman. Suppression of prostaglandin E2 receptor subtype EP2 by PPARγ ligands inhibits human lung carcinoma cell growthBiochemical and Biophysical Research Communications 2004; 314(4): 1093 doi: 10.1016/j.bbrc.2004.01.007
Jiawei Chen, Dayuan Li, Xingjian Zhang, Jawahar L. Mehta. Tumor Necrosis Factor-α-Induced Apoptosis of Human Coronary Artery Endothelial Cells: Modulation by the Peroxisome Proliferator-Activated Receptor-γ Ligand PioglitazoneJournal of Cardiovascular Pharmacology and Therapeutics 2004; 9(1): 35 doi: 10.1177/107424840400900i106
Wei Cui, Chang-Hong Yu, Ke-Qin Hu. In vitro and In vivo Effects and Mechanisms of Celecoxib-Induced Growth Inhibition of Human Hepatocellular Carcinoma CellsClinical Cancer Research 2005; 11(22): 8213 doi: 10.1158/1078-0432.CCR-05-1044
Ivan Borbath, Yves Horsmans, Dipak Panigrahy. The Role of PPARγ in Hepatocellular CarcinomaPPAR Research 2008; 2008(1) doi: 10.1155/2008/209520
M. Sánchez-Hidalgo, A.R. Martín, I. Villegas, C. Alarcón De La Lastra. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in ratsBiochemical Pharmacology 2005; 69(12): 1733 doi: 10.1016/j.bcp.2005.03.024
Kenneth K.W. To, William K.K. Wu, Herbert H.F. Loong. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagyEuropean Journal of Pharmacology 2018; 823: 19 doi: 10.1016/j.ejphar.2018.01.036
Hidenori Haruna, Toshiaki Shimizu, Yoshikazu Ohtsuka, Yukiko Yarita, Tohru Fujii, Takahiro Kudo, Yuichiro Yamashiro. Expression of COX‐1, COX‐2, and PPAR‐γ in the gastric mucosa of children with Helicobacter pylori infectionPediatrics International 2008; 50(1): 1 doi: 10.1111/j.1442-200X.2007.02504.x
Nicole Wagner, Kay-Dietrich Wagner. Peroxisome Proliferator-Activated Receptors and the Hallmarks of CancerCells 2022; 11(15): 2432 doi: 10.3390/cells11152432
Guobin He, You Me Sung, Susan M. Fischer. Troglitazone induction of COX-2 expression is dependent on ERK activation in keratinocytesProstaglandins, Leukotrienes and Essential Fatty Acids 2006; 74(3): 193 doi: 10.1016/j.plefa.2005.12.001
Markus Schwab, Veerle Reynders, Sandra Ulrich, Nadine Zahn, Jürgen Stein, Oliver Schröder. PPARγ is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2Apoptosis 2006; 11(10): 1801 doi: 10.1007/s10495-006-9788-2
Ann K.Y. To, George G. Chen, Ursula P.F. Chan, Caiguo Ye, Jing P. Yun, Rocky L.K. Ho, Art Tessier, Juanita L. Merchant, Paul B.S. Lai. ZBP-89 enhances Bak expression and causes apoptosis in hepatocellular carcinoma cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011; 1813(1): 222 doi: 10.1016/j.bbamcr.2010.09.005
Anett Klopotek, Frank Hirche, Klaus Eder. PPARγ Ligand Troglitazone Lowers Cholesterol Synthesis in HepG2 and Caco-2 Cells via a Reduced Concentration of Nuclear SREBP-2Experimental Biology and Medicine 2006; 231(8): 1365 doi: 10.1177/153537020623100810
Chiara Russo, Margherita Lavorgna, Roberta Nugnes, Elena Orlo, Marina Isidori. Comparative assessment of antimicrobial, antiradical and cytotoxic activities of cannabidiol and its propyl analogue cannabidivarinScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-01975-z
Priyadarshini Raman, Barbara L. F. Kaplan, Jerry T. Thompson, John P. Vanden Heuvel, Norbert E. Kaminski. 15-Deoxy-Δ12,14-prostaglandin J2-Glycerol Ester, a Putative Metabolite of 2-Arachidonyl Glycerol, Activates Peroxisome Proliferator Activated Receptor γMolecular Pharmacology 2011; 80(1): 201 doi: 10.1124/mol.110.070441
Saswati Hazra, Raj K. Batra, Hsin H. Tai, Sherven Sharma, Xiaoyan Cui, Steven M. Dubinett. Pioglitazone and Rosiglitazone Decrease Prostaglandin E2 in Non–Small-Cell Lung Cancer Cells by Up-Regulating 15-Hydroxyprostaglandin DehydrogenaseMolecular Pharmacology 2007; 71(6): 1715 doi: 10.1124/mol.106.033357
Yan Wu, Sun-Wei Guo. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cellsFertility and Sterility 2009; 91(5): 2142 doi: 10.1016/j.fertnstert.2008.04.012
Emmanuelle Berger, Nathalie Vega, Hubert Vidal, Alain Geloën. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survivalBiotechnology Journal 2012; 7(11): 1395 doi: 10.1002/biot.201200188
Hitoshi Ishiguro, Yukari Ishiguro, Yoshinobu Kubota, Hiroji Uemura. Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator‐activated receptor gamma ligand like actionThe Prostate 2007; 67(9): 924 doi: 10.1002/pros.20571
Wei Cui, Shirley X. Hu, Zhen-Ya Tang, Ke-Qin Hu. In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude miceAnti-Cancer Drugs 2008; 19(9): 891 doi: 10.1097/CAD.0b013e32830ef8ca
Katherine A Peebles, Jay M Lee, Jenny T Mao, Saswati Hazra, Karen L Reckamp, Kostyantyn Krysan, Mariam Dohadwala, Eileen L Heinrich, Tonya C Walser, Xiaoyan Cui, Felicita E Baratelli, Edward Garon, Sherven Sharma, Steven M Dubinett. Inflammation and lung carcinogenesis: applying findings in prevention and treatmentExpert Review of Anticancer Therapy 2007; 7(10): 1405 doi: 10.1586/14737140.7.10.1405
Yan Zhang, Yi Ba, Chang Liu, Guoxun Sun, Li Ding, Songyuan Gao, Jihui Hao, Zhentao Yu, Junfeng Zhang, Ke Zen, Zhongsheng Tong, Yang Xiang, Chen-Yu Zhang. PGC-1α induces apoptosis in human epithelial ovarian cancer cells through a PPARγ-dependent pathwayCell Research 2007; 17(4): 363 doi: 10.1038/cr.2007.11
I. Borbath, I. Leclercq, P. Moulin, C. Sempoux, Y. Horsmans. The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liverEuropean Journal of Cancer 2007; 43(11): 1755 doi: 10.1016/j.ejca.2007.05.005
Mei Ming, Jie-Ping Yu, Xiang-Zhi Meng, Yan-Hong Zhou, Hong-Gang Yu, He-Sheng Luo. Effect of ligand troglitazone on peroxisome proliferator-activated receptor γ expression and cellular growth in human colon cancer cellsWorld Journal of Gastroenterology 2006; 12(45): 7263-7270 doi: 10.3748/wjg.v12.i45.7263
Hong-Liang Liang, Qin Ouyang. A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitisWorld Journal of Gastroenterology 2008; 14(1): 114-119 doi: 10.3748/wjg.14.114
Marina Sánchez-Hidalgo, Antonio Ramon Martín, Isabel Villegas, Catalina Alarcón de la Lastra. Rosiglitazone, a PPARγ ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in ratsEuropean Journal of Pharmacology 2007; 562(3): 247 doi: 10.1016/j.ejphar.2007.01.047
Jing Wang, Li Yuan, Haifang Xiao, Chan Wang, Chunxia Xiao, Yutang Wang, Xuebo Liu. A novel mechanism for momordin Ic-induced HepG2 apoptosis: involvement of PI3K- and MAPK-dependent PPARγ activationFood & Function 2014; 5(5): 859 doi: 10.1039/c3fo60558b
Hsiao-Chi Chen, Hui-Tzu Hsu, Jing-Wen Weng, Yuh-Fang Chang, Cheng-Yuan Hsia, Hsin-Chen Lee, Chin-Wen Chi. Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cellsJournal of the Chinese Medical Association 2016; 79(8): 415 doi: 10.1016/j.jcma.2016.03.003
Fausto Bogazzi, Federica Ultimieri, Francesco Raggi, Dania Russo, Renato Vanacore, Chiara Guida, Sandra Brogioni, Chiara Cosci, Maurizio Gasperi, Luigi Bartalena, Enio Martino. Growth Hormone Inhibits Apoptosis in Human Colonic Cancer Cell Lines: Antagonistic Effects of Peroxisome Proliferator Activated Receptor-γ LigandsEndocrinology 2004; 145(7): 3353 doi: 10.1210/en.2004-0225
Siyan Chen, Chong Liu, Xiaoqian Wang, Xiujin Li, Yanling Chen, Nanhong Tang. 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) promotes apoptosis of HBx-positive liver cellsChemico-Biological Interactions 2014; 214: 26 doi: 10.1016/j.cbi.2014.02.009
Dana J. Herrigel, Rebecca A. Moss. Diabetes Mellitus as a Novel Risk Factor for Gastrointestinal MalignanciesPostgraduate Medicine 2014; 126(6): 106 doi: 10.3810/pgm.2014.10.2825
Seo‑Na Chang, Ji Lee, Hanseul Oh, Ukjin Kim, Bokyeong Ryu, Jae‑Hak Park. Troglitazone inhibits the migration and invasion of PC‑3 human prostate cancer cells by upregulating E‑cadherin and glutathione peroxidase 3Oncology Letters 2018;  doi: 10.3892/ol.2018.9278
Radina Kostadinova, Franziska Boess, Dawn Applegate, Laura Suter, Thomas Weiser, Thomas Singer, Brian Naughton, Adrian Roth. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicityToxicology and Applied Pharmacology 2013; 268(1): 1 doi: 10.1016/j.taap.2013.01.012
Gholamreza Houshmand, Mohammad Taghi Mansouri, Bahareh Naghizadeh, Ali Asghar Hemmati, Mahmoud Hashemitabar. Potentiation of indomethacin-induced anti-inflammatory response by pioglitazone in carrageenan-induced acute inflammation in rats: Role of PPARγ receptorsInternational Immunopharmacology 2016; 38: 434 doi: 10.1016/j.intimp.2016.06.027